Explore the words cloud of the WHO-PENatScale project. It provides you a very rough idea of what is the project "WHO-PENatScale" about.
The following table provides information about the project.
| Coordinator |
UNIVERSITATSKLINIKUM HEIDELBERG
Organization address contact info |
| Coordinator Country | Germany [DE] |
| Total cost | 3˙449˙412 € |
| EC max contribution | 3˙449˙412 € (100%) |
| Programme |
1. H2020-EU.3.1.3. (Treating and managing disease) |
| Code Call | H2020-SC1-2018-Single-Stage-RTD |
| Funding Scheme | RIA |
| Starting year | 2019 |
| Duration (year-month-day) | from 2019-01-01 to 2023-06-30 |
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | UNIVERSITATSKLINIKUM HEIDELBERG | DE (HEIDELBERG) | coordinator | 648˙750.00 |
| 2 | CLINTON HEALTH ACCESS INITIATIVE | US (BOSTON) | participant | 1˙222˙042.00 |
| 3 | STICHTING AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT | NL (AMSTERDAM) | participant | 459˙335.00 |
| 4 | GEORG-AUGUST-UNIVERSITAT GOTTINGENSTIFTUNG OFFENTLICHEN RECHTS | DE (GOTTINGEN) | participant | 320˙070.00 |
| 5 | SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT | CH (Basel) | participant | 262˙696.00 |
| 6 | FOLKEHELSEINSTITUTTET | NO (OSLO) | participant | 224˙018.00 |
| 7 | UNIVERSITY OF SWAZILAND | SZ (MAZINI) | participant | 218˙750.00 |
| 8 | SWAZILAND BUSINESS COALITION ON HIVAND AIDS | SZ (MATSAPHA) | participant | 56˙250.00 |
| 9 | DIABETES SWAZILAND | SZ (MANZINI) | participant | 37˙500.00 |
Swaziland has a very high prevalence of both diabetes and hypertension, with the majority of those affected being undiagnosed. Like many other countries in sub-Saharan Africa (SSA), however, Swaziland provides care for diabetes and hypertension only through physician-led teams in hospitals. The country has recently conducted a successful feasibility pilot of the World Health Organisation’s Package of Essential NCD Interventions for Primary Health Care in low-resource settings (WHO-PEN). The WHO-PEN@Scale project aims to improve diabetes and hypertension control at the population-level by helping Swaziland identify and scale up the most effective healthcare delivery model for WHO-PEN implementation at scale. Specifically, we will conduct an innovative nation-wide three-phased adaptive randomised study to i) rigorously assess the effectiveness and cost-effectiveness of three novel community-based healthcare delivery models to scale up WHO-PEN for diabetes and hypertension nationally, ii) study in-depth the real-life implementation of the WHO-PEN national scale-up in Swaziland to generate lessons for other countries, and iii) actively disseminate the Swazi experience along with an open-source toolkit for WHO-PEN scale-up to policy makers in SSA. WHO-PEN@Scale will therefore provide a blueprint of primary health system strengthening for diabetes and hypertension – and ultimately non-communicable diseases (NCDs) more generally - for other countries in the region. WHO-PEN@Scale is highly relevant to this work programme because i) the interventions contained in WHO-PEN have been shown to be cost-effective, ii) the scale-up is government-led, and iii) we assess the impact of WHO-PEN@Scale on diabetes and hypertension control at the population-level.
| year | authors and title | journal | last update |
|---|---|---|---|
| 2019 |
Sascha Lichtenberg, University of Goettingen
Maike Greve, University of Goettingen
Alfred Benedikt Brendel, University of Goettingen
Lutz M. Kolbe, University of Goettingen Towards the Design of a Mobile Application to Support Decentralized Healthcare in Developing Countries – The Case of Diabetes Care in eSwatini published pages: , ISSN: , DOI: |
Twenty-fifth Americas Conference on Information Systems, Cancun, 2019 25th, annual, 2019 | 2019-09-04 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "WHO-PENATSCALE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "WHO-PENATSCALE" are provided by the European Opendata Portal: CORDIS opendata.
Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis
Read MoreIntegrating and decentralising diabetes and hypertension services in Africa
Read MoreFLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA
Read More